← Leaderboards
Donald G Phinney
Tulane University Of Louisiana
$12,507,245
Attributed
$12,507,245
Total exposure
20
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,507,245 · 20
By mechanism
R01$8,167,307 · 3
R24$2,603,898 · 1
P01$912,247 · 1
P51$823,793 · 15
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Xiaoying Wang$10,717,451
- Pete J Didier$2,580,809
- Carl A Gregory$3,026,843
- Eva-Maria Ratai$5,301,549
Others in their field
Top investigators on “Mesenchymal Stem Cells”
- Ralph Parchment · Leidos Biomedical Research, Inc.$30,925,921
- Joshua M Hare · Johns Hopkins University$24,486,057
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Darwin Johnson Prockop · Thomas Jefferson University$20,016,289
- Bing Ren · Ludwig Institute For Cancer Research$17,040,291
- Richard E. Champlin · University Of Texas Md Anderson Can Ctr$16,195,855
Research focus
Mesenchymal Stem CellsCellsResearch PersonnelAffectBone MarrowAnimal ModelMacaca MulattaSafetyBehaviorResourcesCell TherapyInstitutionPre-ClinicalBaseStem CellsFundingTreatment EfficacyClinical TrialsHuman DiseaseInfantBrainAnimalsLaboratoriesEngraftment
Grant awards (45)
A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells$831,359
R01 · FY2025 · HL · contact PI
A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells$827,141
R01 · FY2024 · HL · contact PI
A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells$571,231
R01 · FY2021 · HL · contact PI
A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells$189,702
R01 · FY2021 · HL · contact PI
A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells$760,933
R01 · FY2020 · HL · contact PI
A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells$805,933
R01 · FY2019 · HL · contact PI
A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells$656,305
R01 · FY2018 · HL · contact PI
Species-specific and Systems Biology Approach to MSC-based Therapies$621,021
R24 · FY2017 · OD · contact PI
Species-specific and Systems Biology Approach to MSC-based Therapies$654,187
R24 · FY2016 · OD · contact PI
Species-specific and Systems Biology Approach to MSC-based Therapies$29,235
R24 · FY2016 · OD · contact PI
Species-specific and Systems Biology Approach to MSC-based Therapies$655,689
R24 · FY2015 · OD · contact PI
Species-specific and Systems Biology Approach to MSC-based Therapies$643,766
R24 · FY2014 · OD · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$53,995
P51 · FY2011 · RR · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$37,186
P51 · FY2011 · RR · contact PI
Pre-Clinical Trial of MSC-Based Therapy for CNS Disease$493,042
R01 · FY2010 · NS · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$65,759
P51 · FY2010 · RR · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$61,801
P51 · FY2010 · RR · contact PI
Pre-Clinical Trial of MSC-Based Therapy for CNS Disease$551,827
R01 · FY2009 · NS · contact PI
CORE--Morphology$177,249
P01 · FY2009 · HL · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$64,877
P51 · FY2009 · RR · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$55,742
P51 · FY2009 · RR · contact PI
Pre-Clinical Trial of MSC-Based Therapy for CNS Disease$545,909
R01 · FY2008 · NS · contact PI
CORE--Morphology$169,069
P01 · FY2008 · HL · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$55,151
P51 · FY2008 · RR · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$23,596
P51 · FY2008 · RR · contact PI
Pre-Clinical Trial of MSC-Based Therapy for CNS Disease$560,910
R01 · FY2007 · NS · contact PI
CORE--Morphology$193,377
P01 · FY2007 · HL · contact PI
Marrow stromal cells for Lysosomal Disease CNS Defects$186,250
R01 · FY2007 · NS · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$103,635
P51 · FY2007 · RR · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$30,254
P51 · FY2007 · RR · contact PI
CORE--Morphology$188,969
P01 · FY2006 · HL · contact PI
Marrow stromal cells for Lysosomal Disease CNS Defects$74,500
R01 · FY2006 · NS · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$34,958
P51 · FY2006 · RR · contact PI
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$30,971
P51 · FY2006 · RR · contact PI
CORE--Morphology$183,583
P01 · FY2005 · HL
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$37,662
P51 · FY2005 · RR
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$33,521
P51 · FY2005 · RR
Marrow stromal cells for Lysosomal Disease CNS Defects$259,875
R01 · FY2004 · NS
SAFETY: MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS$46,011
P51 · FY2004 · RR
SAFETY OF MESENCHYMAL STEMCELL ADMINISTRATION TO THE CNS$35,475
P51 · FY2004 · RR
Marrow stromal cells for Lysosomal Disease CNS Defects$259,875
R01 · FY2003 · NS
SAFETY OF MESENCHYMAL STEM CELL ADMINISTRATION TO THE CNS OF RHESUS MACAQUES$53,199
P51 · FY2003 · RR
Marrow stromal cells for Lysosomal Disease CNS Defects$259,875
R01 · FY2002 · NS
Marrow stromal cells for Lysosomal Disease CNS Defects$72,765
R01 · FY2002 · NS
Marrow stromal cells for Lysosomal Disease CNS Defects$259,875
R01 · FY2001 · NS